|
|
Volumn 38, Issue 3, 2004, Pages 247-249
|
|
Treatment of ulcerative colitis with infliximab: are we there yet?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
GASTROINTESTINAL AGENT;
IMMUNOSUPPRESSIVE AGENT;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
HUMAN;
IMMUNOLOGY;
NOTE;
REMISSION;
TREATMENT OUTCOME;
ULCERATIVE COLITIS;
ANTI-INFLAMMATORY AGENTS;
ANTIBODIES, MONOCLONAL;
COLITIS, ULCERATIVE;
GASTROINTESTINAL AGENTS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
REMISSION INDUCTION;
TREATMENT OUTCOME;
|
|
EID: 5044229383
PISSN: 02772116
EISSN: 15364801
Source Type: Journal
DOI: 10.1097/00005176-200403000-00005 Document Type: Editorial |
|
Times cited : (6)
|
|
References (0)
|
